Quantcast

Latest gastric cancer Stories

2014-09-18 08:26:01

-- Phase III RAINBOW Trial Data Published in The Lancet Oncology -- INDIANAPOLIS, Sept. 18, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that results of the global Phase III trial of ramucirumab (CYRAMZA(TM)) in combination with paclitaxel in patients with advanced gastric (stomach) cancer or gastroesophageal junction (GEJ) adenocarcinoma were published in the online version of The Lancet Oncology. In the trial, known as RAINBOW, the addition of ramucirumab to...

2014-07-15 08:28:57

MADISON, Wis., July 15, 2014 /PRNewswire/ -- No Stomach For Cancer is pleased to announce two $50,000 grant awards to fund exploration of the development of gastric cancer. In keeping with the organization's mission, these grants will facilitate research projects that hold the promise of improving prevention, diagnosis and treatment of this deadly disease. Photo - http://photos.prnewswire.com/prnh/20140714/126708 The first research grant will support Dr. David Huntsman from the...

2014-07-07 09:57:58

NUS New study by Cancer Science Institute of Singapore at NUS show that the protein is produced as an immune response and requires the tumour suppressor RUNX3 A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) discovered that a protein named IL23A is part of our stomach’s defense against bacterial infection which leads to gastric cancer. This finding could potentially be used to combat the deadly disease....

2014-06-13 08:24:14

Research grant recipient will be studying the contribution of the polycomb repressive complex (PRC2) towards gastric cancer progression. FT. LAUDERDALE, Fla., June 13, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF), a non-profit organization that raises awareness and funds for stomach cancer, launched its first research grant of $50,000 for a Young Fellowship Award. The organization presented Dr. David Allison with the fellowship on April 5, 2014 at the...

2014-04-21 23:03:08

New research report “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends...

2014-04-21 20:21:44

INDIANAPOLIS, April 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved CYRAMZA(TM) (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction (GEJ) adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. With this approval, CYRAMZA becomes the first FDA-approved treatment for patients...

2014-04-03 12:30:00

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth SummaryGBI Research has released the pharma report "Monoclonal...

2014-01-13 08:29:07

PHILADELPHIA, Jan. 13, 2014 /PRNewswire/ -- The American Association for Cancer Research (AACR) and Debbie's Dream Foundation: Curing Stomach Cancer (DDF) are pleased to announce a new fellowship opportunity in gastric cancer research. (Photo: http://photos.prnewswire.com/prnh/20140113/PH44438 ) The Debbie's Dream Foundation-AACR Gastric Cancer Fellowship represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct gastric cancer research...

2013-12-20 23:01:01

An international team of researchers led by UC Davis in collaboration with scientists in Mexico and South Korea have taken a first step towards identifying glycans — sugars attached to proteins — that could help clinicians diagnose gastric cancer before it becomes deadly. Their research was published in the journal Cancer Prevention Research. Sacramento, CA (PRWEB) December 20, 2013 Gastric cancer kills more than 700,000 people each year, mostly in Latin America, Asia and Eastern...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'